Asthma and Chronic Obstructive Pulmonary Disease (COPD) are two of the most common problems people have throughout the world. Asthma affects over 23 million Americans alone and COPD is one of the costliest conditions to treat as well as a leading cause of death (one death every four minutes in the United States). COPD is the fourth leading cause of death in the United States.
Through the use of disease specific symptom journals and extremely portable credit card sized devices that measure oxygen levels, pulse, volitle organic compounds as well as spirometry, iMPak Health has added kits for pulmonary chronic disease management to its product portfolio. While the kit is targeted for either Chronic Obstructive Lung Disease (COPD) or Adult Asthma, they are extremely flexible enabling bundling of capabilities to help individuals and practitioners manage multiple conditions with the same "touch and post" method.